RE:RE:Stock PsychologyHello Canada and as we all know the potential is huge especially for panc. I would not count on mbc too much at this moment as the guidance from the prospectus is only half a million for the mbc as compared to over 10 million for the panc and implementation of the trial. Hard to tell from the prospectus if this means they will try to go it alone or that would be their portion to take the trial to start up...
As for valuation, I agree, a phase 3 company is worth a lot more for sure but how much is the big question. Will past history play into things, will the timing affect it or if they try to go it alone or with a partner....I believe that a partner would add more credibility for sure as they would want to be a part of the ride up... IMO only if we try to go it alone without a partner other than precision then the company would be ripe for a BO later into the trial as there would then be no need for a partner....So very curious what the protocols and the 90 days bring as to the definitive agreements and to whether a CI will be announced at this time....Hang on to your hats as this could get very interesting and the larger volume the last couple of days kinda suggests the same IMO.